Literature DB >> 30582612

Voice outcomes following medialization laryngoplasty with and without arytenoid adduction.

Terence M Zimmermann1, Diana M Orbelo1, Rebecca L Pittelko1, Stephanie J Youssef2, Christine M Lohse3, Dale C Ekbom1.   

Abstract

OBJECTIVE: Voice outcomes following medialization laryngoplasty (ML) for unilateral vocal fold paralysis (UVFP) were compared to those who underwent ML plus arytenoid adduction (AA) (ML+AA).
METHODS: Single institution retrospective review of patients with UVFP undergoing ML and ML+AA (2009-2017). Demographic information and history of laryngeal procedures were collected. Preoperative and postoperative Voice Handicap Index-10 (VHI-10) and Consensus Perceptual Auditory Evaluation of Voice (CAPE-V) were assessed.
RESULTS: Of 236 patients, 119 met study criteria. Of those, 70 (59%) underwent ML and 49 (41%) underwent ML+AA. Significant differences between groups at baseline were found for age at time of thyroplasty (P = 0.046), VHI-10 scores (P < 0.001), and CAPE-V scores (P = 0.007). Baseline VHI-10 scores for ML+AA (28 ± 7) were greater than those for ML alone (24 ± 7). At 12 months, overall VHI-10 scores improved compared to baseline for both groups (ML+AA = 9 ± 7, ML = 16 ± 9); however, there was greater improvement for the ML+AA group compared to ML group (P = 0.001). CAPE-V scores at 3 or 12 months improved, but differences between the groups were not statistically significant once controlled for covariates.
CONCLUSION: Based on current findings, patients who undergo ML+AA likely have greater voice handicap at baseline compared to those undergoing ML alone. Patients selected for ML+AA improve as much or more than those who underwent ML alone. This highlights the importance of appropriate selection of candidates for AA. LEVEL OF EVIDENCE: 4 Laryngoscope, 129:1876-1881, 2019.
© 2018 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Consensus Perceptual Auditory Evaluation of Voice; Medialization laryngoplasty; Voice Handicap Index-10; arytenoid adduction

Mesh:

Year:  2018        PMID: 30582612     DOI: 10.1002/lary.27684

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  3 in total

Review 1.  A narrative review of current therapies in unilateral recurrent laryngeal nerve injury caused by thyroid surgery.

Authors:  Hedi Tian; Jun Pan; Linghui Chen; Yijun Wu
Journal:  Gland Surg       Date:  2022-01

2.  Type I Thyroplasty Using a Titanium Implant Combined With Modified Arytenoid Adduction.

Authors:  Koji Matsushima
Journal:  Laryngoscope       Date:  2020-07-03       Impact factor: 3.325

3.  Voice assessment of fat injection vs medialization laryngoplasty in nonparalytic dysphonia.

Authors:  Sarah K Rapoport; Thomas Murry; Peak Woo
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-05-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.